Brain Chip Breakthrough: Promising Depression Treatment

by Feb 13, 2024Neuroana0 comments

In a groundbreaking development, biotech startup Motif Neurotech is pioneering a brain implant designed to offer hope to individuals suffering from treatment-resistant depression. Originally conceived as a research project at Rice University, Motif Neurotech has secured a substantial $18.75 million in Series A funding, led by Arboretum Ventures, to propel its innovative technology forward.

The brain implant, still in the developmental stage, has not undergone comprehensive human testing or clinical trials. Despite the funding injection, trials to assess its safety and efficacy in treating depression are likely years away, and the company has not provided a specific timeline for these crucial milestones. Instead, Motif Neurotech plans to utilize the funding to advance the development of its flagship product—a fingertip-sized, battery-free implant known as the DOT microstimulator. Click here to read more. 

Let’s Engage!

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Read More

🌟🧠The Power of Consciousness: Why Awareness is Fundamentally Important🧠✨

#Consciousness is a profound and transformative aspect of our existence. When we are conscious, we gain the ability to observe and understand our thoughts, feelings, and actions rather than being driven solely by our subconscious mind. Often, our subconscious operates...

Revisiting Your Memory: Reconstruction of Affect-Contextualized Memory viaEEG-guided Audiovisual Generation

💭 CanEEG signals help reconstruct our most cherished memories? A study using our Enobio system explores how EEG-guided affect decoding can generate personalized audiovisual content, preserving the emotional essence of autobiographical memories....

Low-Power Brain Chip Predicts Users’ Intentions 

Brain-chip technology is quickly accelerating. In one of the latest advancements, researchers have designed a new chip that uses larger groups of neurons and less power to detect when a user wants to initiate a given behavior—for example, reaching for an object. The...

Gamification of recoveriX Neurorehabilitation 

The lower limb therapy now features the Virtual Reality drum game 🪘🪘. Many stroke and multiple sclerosis patients have already tested it and really like it. Patients have to imagine either foot or hand movements, which the BCI system detects and...

“A big part of my ‘why’ that I’ve never shared is that my family has struggled with mental illness”

"A big part of my 'why' that I've never shared is that my family has struggled with mental illness" - Georgia V. co-founder of Human HealthGeorgia is a superhuman and one of the most impressive people I've met. She was head of product at Canva in her 20s and is...

Neurable & Healthspan Digital Join Forces

Neurable Inc. and Healthspan Digital Inc. have formed a partnership to bring brain-computer interface technology to precision health and longevity clinics. This collaboration aims to introduce Neurable’s advanced brain health tools to a wider audience. Neurable is...

Wearable Brain Devices Market Size, Outlook, Key Players, Revenue, Latest Trends, and Forecast 2028

Wearable technology refers to any technology that can be used while wearing. Wearable technology includes smartwatches and smart glasses. Many wearable electronic devices are placed on or near the skin's surface. They detect, analyze and transmit information, such as...

Brain-Computer Interfaces Are Becoming Immensely Popular

One of the boldest emerging sciences is the field of brain-computer interfaces (BCIs). Broadly speaking, BCIs are essentially tools by which brain signals and thoughts can be relayed into tangible outputs independent of a person’s native muscular functions. The most...

Neurological conditions now leading cause of ill-health worldwide, finds study

Neurological conditions ranging from migraine to stroke, Parkinson’s disease and dementia, are now the leading cause of ill-health worldwide, causing 11.1 million deaths in 2021, research has revealed. The number of people living with or dying from disorders of the...

Even more evidence of the value of TMS Therapy

New data has recently been published providing compelling evidence that clinicians should consider repetitive transcranial magnetic stimulation (TMS) much earlier for patients who do not respond to antidepressant medication. The study focused on 278 individuals...